The global healthcare industry has redefined treatment standards. Where traditional therapies culminated in invasive and extensive surgeries that posed significant risks to the patients, with the onset of advanced medical research, healthcare professionals are shifting to more viable alternatives such as those offered by Regenerative medicine –– specifically Stem Cell Therapy.
Stem Cell therapy is unique in its effect and has opened a completely novel chapter of long-term disease treatment. Many chronic conditions such as cardiovascular disease, structure-based ailments such as osteoarthritis, and inflamed wounds are a consequence of the same underlying condition- tissue damage. Stem Cell Therapy aims to root out his foundational problem, and organically repair damaged cells and tissues.
According to Denver Stem Cell Doctor Scott Brandt, this therapy has potential to cure some diseases without the need for certain invasive surgeries. Because of the revolutionary benefits offered by Stem Cell Therapy, the market is adjusting to its popularity. Senior financial analysts predict that the field of regenerative medicine will continue to enjoy sustained positive growth, and support from intersecting medical sectors.
The initiatives of Stem Cell therapy are leaving profound impressions over private and public investors. Venture capitalists within the realm of healthcare have assessed the cross-functional potential of Stem Cell therapy. Because the treatments under regenerative medicine are related to genetics and immunology, the requirement of world-class laboratory facilities is essential for this investment to reign.
Major pharma companies have also taken an increased interest in this domain, many of which have set their own facilities that are providing regenerative solutions to chronic ailments, and acquired stocks in prominent stem cell therapy companies.
Given the financial assessment, stem cell therapy is the fastest-growing medical trend. The global stem cell market is expected to reach a staggering amount of $40 billion by 2020, only to increase to over $150 billion by 2030.
This outrageous increase in the worth of a novel medical field isn’t unwarranted. The benefits that Stem Cell therapy offers is unprecedented. To make sense of how Stem Cells actually work, understand this.
Stem Cell specimens that are injected in the patient’s body become the raw material for repair. There are two benefits that this quality offers. First, if there is tissue damage that is causing a bodily system to malfunction, these cells can organically grow and fulfill any cell-based deficiency.
Secondly, stem cells also have the ability to grow into highly specialized cells. For example, cardiovascular disease is caused by injured heart tissue that doesn’t get enough oxygen to respire. If a stem cell specimen is injected to treat this chronic condition, then the deficiency of degenerated tissue can be overcome, preventing the need for invasive surgery.
Despite the soaring popularity and potential offered to the realm of healthcare treatments, there exist areas of concern for the regenerative medicine niche. There is a lack of funding in the early stages and an arbitrary deviation in the manufacturing of living cells. Contrary to these complications, investor confidence is still expected to grow for early and mid-stage clinical trials, as this consumer market has already shown that it is a trump-card.